GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
Abstract Background G protein-coupled receptor (GPCR) is the most targeted protein family by the FDA-approved drugs. GPCR-kinase 3 (GRK3) is critical for GPCR signaling. Our genomic analysis showed that GRK3 expression correlated with poor prognosis of gastric adenocarcinoma (GAC) patients. However,...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2022-08-01
|
| coleção: | Journal of Experimental & Clinical Cancer Research |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s13046-022-02463-6 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
